Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
L Vidal, M Paul, N Eliakim‐Raz… - Cochrane Database …, 2013 - cochranelibrary.com
Background Fever occurring in a neutropenic patient remains a common life‐threatening
complication of cancer chemotherapy. The common practice is to admit the patient to …
complication of cancer chemotherapy. The common practice is to admit the patient to …
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
L Vidal, IB Dor, M Paul… - The Cochrane …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Fever occurring in a neutropenic patient remains a common life-threatening
complication of cancer chemotherapy. The common practice is to admit the patient to …
complication of cancer chemotherapy. The common practice is to admit the patient to …
[引用][C] Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
L VIDAL - Cochrane Database Syst Rev., 2004 - cir.nii.ac.jp
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[HTML][HTML] Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
L Vidal, M Paul, N Eliakim‐Raz, E Pokroy… - The Cochrane …, 2013 - ncbi.nlm.nih.gov
Background Fever occurring in a neutropenic patient remains a common life‐threatening
complication of cancer chemotherapy. The common practice is to admit the patient to …
complication of cancer chemotherapy. The common practice is to admit the patient to …
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
L Vidal, M Paul, E Pokroy… - Cochrane Database …, 2004 - cochranelibrary.com
Background Fever occurring in a neutropenic patient remains a common life‐threatening
complication of cancer chemotherapy. The common practice is to admit the patient to …
complication of cancer chemotherapy. The common practice is to admit the patient to …
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
L Vidal, B Dor, M Paul, N Eliakim-Raz… - The Cochrane …, 2013 - europepmc.org
Background Fever occurring in a neutropenic patient remains a common life-threatening
complication of cancer chemotherapy. The common practice is to admit the patient to …
complication of cancer chemotherapy. The common practice is to admit the patient to …
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
L Vidal, M Paul, I Ben-Dor, E Pokroy… - The Cochrane …, 2004 - pubmed.ncbi.nlm.nih.gov
Background Fever occurring in a neutropenic patient remains a common life-threatening
complication of cancer chemotherapy. The common practice is to admit the patient to …
complication of cancer chemotherapy. The common practice is to admit the patient to …
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
L Vidal, M Paul, I Ben-Dor, E Pokroy… - The Cochrane …, 2004 - europepmc.org
Background Fever occurring in a neutropenic patient remains a common life-threatening
complication of cancer chemotherapy. The common practice is to admit the patient to …
complication of cancer chemotherapy. The common practice is to admit the patient to …
[引用][C] Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients
L VIDAL - Cochrane Database Syst Rev., 2004 - cir.nii.ac.jp
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …